Who invested in IGM Biosciences?
IGM Biosciences's investors include Janus Henderson Investors, Vivo Capital and Redmile Group.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$209Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $23M sold, first sale Jun 2023
From the SEC filings it signed: 6 on the team.
On the board, as filediChristina Teng TopsoeFelix J. BakerJakob Haldor TopsoeJulie J. HambletonM. Kathleen J. BehrensMichael J. LeeMichael J. LobergWilliam J. Strohl
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
IGM Biosciences's investors include Janus Henderson Investors, Vivo Capital and Redmile Group.
IGM Biosciences has raised $209M across 2 rounds since 2019.
IGM Biosciences's most recent round was an Undisclosed round of $107M in Jun 2023.
Its most recent round, $107M in Jun 2023, is also its largest on record.
IGM Biosciences's first round on record, in Jul 2019, was backed by Janus Henderson Investors, Vivo Capital and Redmile Group.
IGM Biosciences's latest named round is an Undisclosed round, in Jun 2023.
IGM Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.